Related Experiment Video
Updated: Aug 22, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
The secretable form of trimeric TRAIL, a potent inducer of apoptosis
Mi-Hyang Kim1, Timothy R Billiar, Dai-Wu Seol
1Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Abstract:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane cytokine molecule of the TNF family. Soluble recombinant TRAIL has been shown to induce apoptosis in a wide variety of cancer cells in vitro and to specifically limit tumor growth without damaging normal cells and tissues in vivo. These results suggest a strong potential of TRAIL as an anticancer therapy. Here we report an artificial TRAIL gene that expresses and secretes trimeric TRAIL into the culture supernatant. This novel TRAIL gene is composed of three functional elements, including a secretion signal, a trimerization domain, and an apoptosis-inducing moiety of TRAIL gene sequence. The expression vectors delivering this TRAIL gene produced secretable forms of trimeric TRAIL proteins. These TRAIL proteins showed greater apoptotic activity than the known TRAIL protein that does not contain an additional trimerization domain. Our data suggest that the gene therapy using our artificial TRAIL gene may be used as an anticancer therapy.
Insights
Researchers engineered an artificial Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) gene. This novel gene enhances cancer cell apoptosis, offering a promising new avenue for anticancer gene therapy.
Area of Science:
- Molecular Biology
- Immunology
- Cancer Research
Background:
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a cytokine that induces apoptosis in cancer cells.
- Soluble recombinant TRAIL shows potential for cancer therapy by limiting tumor growth without harming normal tissues.
- Existing TRAIL proteins have limitations in efficacy.
Purpose of the Study:
- To develop an artificial TRAIL gene for enhanced secretion and apoptotic activity.
- To investigate the potential of this novel gene in anticancer gene therapy.
Main Methods:
- Constructed an artificial TRAIL gene incorporating a secretion signal, trimerization domain, and apoptosis-inducing moiety.
- Utilized expression vectors to produce secretable, trimeric TRAIL proteins.
- Assessed the apoptotic activity of the engineered TRAIL proteins in vitro.
Main Results:
- The artificial TRAIL gene successfully expressed and secreted trimeric TRAIL into culture supernatant.
- The secreted trimeric TRAIL proteins exhibited enhanced apoptotic activity compared to conventional TRAIL.
- Demonstrated increased efficacy in inducing cancer cell apoptosis.
Conclusions:
- The engineered artificial TRAIL gene holds significant potential for developing novel anticancer therapies.
- Gene therapy utilizing this artificial TRAIL gene may offer an effective strategy against various cancers.
- The enhanced apoptotic activity suggests improved therapeutic outcomes.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Caspases
TGF - β Signaling Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

